Copyright © 2001 by the European Society of Cardiology.
Evolution of percutaneous transluminal coronary angioplasty in Europe from 19921996
a Cardiology, Swiss Cardiovascular Bern, Bern, Switzerland
b Clinical Epidemiology, Thoraxcenter, Erasmus University, Rotterdam Dijkzigt, The Netherlands
revised April 10, 2001; accepted April 11, 2001
Abstract
Background The working group Coronary Circulation of the European Society of Cardiology has been conducting a yearly survey on coronary interventions in Europe. The purpose of this study is to present the evolution of percutaneous transluminal coronary angioplasty (PTCA) with epidemiological and economic implications.
Methods Coronary interventions were polled by questionnaires distributed to all institutions performing cardiac catheterization. Aggregated country data of the years 19921996 on indication, type of procedure, technique, and outcome of coronary interventions were analysed.
Results Population-adjusted coronary angiographies and PTCA procedures increased by 76% and by 105%, respectively. The Percentage of coronary stenting increased from zero to almost half of all procedures. Analysis per country groups reveals considerable variation, ranging, e.g. for PTCA in 1996 from 157 procedures per million population in a group of eastern countries to 1138 in a central European group. Relating total revascularization (R) to standardized death rate for ischaemic heart disease (SDR) and to gross domestic product (GDP), there was an increase from 1·0 to 1·8 R/SDR and 40 to 61 R/GDP in the central European group compared with an increase from 0·06 to 0·18 R/SDR and 43 to 85 R/GDP in the eastern group.
Conclusions An overall increase in PTCAs at an annual rate between 15 and 25% was observed. The wide variation in the use of PTCA in Europe appears to be dependent mostly on economic factors and national health care policies.
Key Words: Angioplasty, epidemiology, statistics
f1 Current address: Cardiology, University Hospital Zurich, Zurich, Switzerland.
f2 Correspondence: Bernhard Meier, MD, Professor and Chairman, Swiss Cardiovascular Center Bern, University Hospital, 3010 Bern, Switzerland.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S Stewart, N Murphy, A Walker, A McGuire, and J J V McMurray The current cost of angina pectoris to the National Health Service in the UK Heart, August 1, 2003; 89(8): 848 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Sousa, P. W. Serruys, and M. A. Costa New Frontiers in Cardiology: Drug-Eluting Stents: Part I Circulation, May 6, 2003; 107(17): 2274 - 2279. [Full Text] [PDF] |
||||
![]() |
W. Maier, P. Camici, S. Windecker, D. Pfiffner, W. Wijns, and B. Meier The European Registry of Cardiac Catheter Interventions 1997 Eur. Heart J., December 2, 2002; 23(24): 1903 - 1907. [PDF] |
||||
![]() |
S. Fuchs, E. Stabile, T. D. Kinnaird, G. S. Mintz, L. Gruberg, D. A. Canos, E. E. Pinnow, R. Kornowski, W. O. Suddath, L. F. Satler, et al. Stroke Complicating Percutaneous Coronary Interventions: Incidence, Predictors, and Prognostic Implications Circulation, July 2, 2002; 106(1): 86 - 91. [Abstract] [Full Text] [PDF] |
||||


